Cite
PO-1244 Severe surgical morbidity after chemoradiotherapy conformational-3D versus IMRT for rectal cancer.
MLA
Martin, M., et al. “PO-1244 Severe Surgical Morbidity after Chemoradiotherapy Conformational-3D versus IMRT for Rectal Cancer.” Radiotherapy & Oncology, vol. 161, Aug. 2021, pp. S1026–28. EBSCOhost, https://doi.org/10.1016/S0167-8140(21)07695-7.
APA
Martin, M., Giraud, N., Capdepont, M., Sarrade, C., Viaouet, A., Smith, D., Terrebonne, E., Frulio, N., Rullier, A., Denost, Q., Rullier, E., & Vendrely, V. (2021). PO-1244 Severe surgical morbidity after chemoradiotherapy conformational-3D versus IMRT for rectal cancer. Radiotherapy & Oncology, 161, S1026–S1028. https://doi.org/10.1016/S0167-8140(21)07695-7
Chicago
Martin, M., N. Giraud, M. Capdepont, C. Sarrade, A. Viaouet, D. Smith, E. Terrebonne, et al. 2021. “PO-1244 Severe Surgical Morbidity after Chemoradiotherapy Conformational-3D versus IMRT for Rectal Cancer.” Radiotherapy & Oncology 161 (August): S1026–28. doi:10.1016/S0167-8140(21)07695-7.